一个H2O2自我供应和氧气进化的纳米系统用于扩大乳腺癌的化学动力学治疗
Yijun Wu1, Longxia Li1, Lechen Jia1
1School of Pharmacy, Henan University, Kaifeng 475004, China.
Colloids and surfaces. B, Biointerfaces
|December 14, 2025
概括
这项研究引入了一种新型纳米系统,通过克服低H2O2水平和瘤缺氧来增强乳腺癌的化学动力学治疗 (CDT). 该系统有效地产生细胞毒性基因,导致强大的瘤抑制,副作用最小.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术 纳米技术
- 在瘤学瘤学.
背景情况:
- 乳腺癌仍然是全球癌症死亡的主要原因.
- 化学动力学疗法 (CDT) 是有前途的,但受到不足的H2O2,瘤缺氧和谷氨 (GSH) 防御的限制.
- 现有的CDT策略需要加强,以克服生物障碍.
研究的目的:
- 开发一个多功能纳米系统,以克服乳腺癌化学动力学治疗的局限性.
- 通过解决低内H2O2,缺氧和GSH介导的耐药性来提高治疗疗效.
- 研究二氧化纳米颗粒和β-lapachone的协同效应,以改善瘤抑制.
主要方法:
- 开发一个含有β-lapachone (HML) 的氧化物纳米粒子系统.
- 在瘤微环境中对HML纳米系统的性能进行了体外和体内评估.
- 评估HML通过芬顿类反应消耗GSH,产生氧气和产生基的能力.
主要成果:
- 在酸性和富含GSH的瘤环境中,HML纳米系统有效地分解,释放了Mn2+和β-lapachone.
- 同步释放的Mn2+和β-lapachone耗尽了GSH,改善了瘤缺氧,并产生了H2O2.
- 在实验室和体内,HML系统诱导了显著的瘤细胞亡和强大的瘤抑制,副作用最小.
结论:
- 开发的HML纳米系统为增强乳腺癌化学动力学治疗提供了一个有效的策略.
- 这种方法成功地解决了多种生物障碍,包括缺氧和氧化应激抵抗.
- 这项研究为改善乳腺癌治疗结果提供了一种有前途的治疗方式.
相关概念视频
02:49Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
01:46Electron Transport Chain: Complex I and II
18.4K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
18.4K
02:53Adaptive Mechanisms in Cancer Cells
6.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.9K